Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence

A fixed-dose combination of inhaled corticosteroid and long-acting beta agonist (ICS/LABA) may increase the risk of pneumonia in patients with chronic airway diseases including chronic obstructive pulmonary disease and asthma. Although lung deposition of ICS/LABA is dependent on the inhaler device a...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ju-Hee, Kim, Yunjung, Choi, Seongmi, Jang, Eun Jin, Kim, Jimin, Lee, Chang-Hoon, Yim, Jae-Joon, Yoon, Ho-il, Kim, Deog Kyeom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700062/
https://www.ncbi.nlm.nih.gov/pubmed/31427602
http://dx.doi.org/10.1038/s41598-019-48355-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700062/
https://www.ncbi.nlm.nih.gov/pubmed/31427602
http://dx.doi.org/10.1038/s41598-019-48355-2

Ejemplares similares